Idorsia Ltd

Idorsia Ltd

World Rank (Jan-05-2024)
13,426
Market Cap (Jan-05-2024)
0.438 Billion USD
World Rank (Jul-30-2023)
7,285
Market Cap (Jul-30-2023)
1.359 Billion USD
World Rank (Jan-07-2022)
4,316
Market Cap (Jan-07-2022)
3.531 Billion USD
World Rank (Jan-01-2021)
3,053
Market Cap (Jan-01-2021)
4.755 Billion USD
Headquarters Country
Switzerland
World Region
Europe
World Subregion
Western Europe
Annual Revenue in USD
37 Million USD
Annual Net Income in USD
-678 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
1,586 Million USD
Total Liabilities in USD
1,474 Million USD
Total Equity in USD
111 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Company Website
IDORSIA LTD
Yahoo
Yahoo @ Switzerland
Company Profile
Idorsia Ltd is the leading Biopharmaceutical company specialized in the discovery, development and commercialization of innovative small molecules with the aim of transforming the horizon of therapeutic options. The headquarters is in Switzerland.
Facts About Company
The company annual revenue was 97 million CHF and annual net loss was -827 million CHF for year ending Dec-2022.
Founded Year
2017
Stock Exchange
Switzerland
Company SubCategory
Top Healthcare Companies in Europe

Share